English press releases

Philip Morris International Introduces New Biodiversity and Water Ambitions and Announces Achievement of ‘Triple A’ from the CDP

The new biodiversity and water ambitions are introduced in a dedicated report that outlines PMI’s approach to preserve nature, building on its 2025 Roadmap LAUSANNE,...

Weather Forecasting Set to Enter a New Era With Tonight’s Launch of Next-generation Satellite

New-generation satellite carries more advanced instruments for monitoring and forecasting severe weather events DARMSTADT, Germany–(BUSINESS WIRE)– Tonight’s launch of a highly advanced meteorological satellite from,...

Sisvel Announces the Launch of the 5G Multimode (5G MM) Licensing Program

LUXEMBOURG–(BUSINESS WIRE)– Sisvel International S.A. (“Sisvel”) today announced the launch of its 5G Multimode (5G MM) Licensing Program. The 5G MM Program offers a single...

Thales Awarded the 2022 Frost & Sullivan Global Software License and Entitlement Market Leadership Award

Thales is at the forefront of innovation and growth in the software monetization industry, driving a growth strategy against disruptive technologies, value chain compression, and...

JT Group Recognized on CDP’s “Climate Change A List” for the 4th Consecutive Year

TOKYO–(BUSINESS WIRE)– Japan Tobacco Inc. (JT) (TSE: 2914) has once again been recognized for its leadership in corporate sustainability by the global environmental non-profit organization...

Cancellation of remaining publicly held registered shares of Vifor Pharma AG

Last trading day of Vifor registered shares: 22 December 2022 Delisting date of Vifor registered shares: 23 December 2022 Regulatory News: AD HOC ANNOUNCEMENT PURSUANT...

Digital Integrator Cohesive Group Acquires Vetasi, Leading Provider of IBM Maximo Managed Services

Enhancing its Position as a Global Partner for EAM Operational Excellence, Expanding Market Capacity and Geographical Reach EXTON, Pa.–(BUSINESS WIRE)– Bentley Systems, Incorporated (Nasdaq: BSY),...

Officeworks Leverages Rimini Connect™ for Browsers to Maintain Business-Critical Customer Support and Avoid Costly, Disruptive SAP Software Upgrade

Following the retirement of the IE11 browser, Officeworks maintained smooth and continuous functionality of critical CRM and customer support systems which relied on the browser...

KPMG delivers strong global revenues, reporting 14% growth in FY22

Highlights include: Strong financial performance against challenging economic backdrop underlining the resilience of our multi-disciplinary global organization Reported aggregated revenues for KPMG firms globally of...

European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares

EC grants conditional marketing authorization based on the EFFISAYIL® 1 trial, which demonstrated that over half of the spesolimab-treated patients were free of pustules, one...

Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study

Study shows Velo consumers had significantly better results for several indicators linked to smoking-related diseases compared with smokers Results provide important new data and insights...

MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program

GHENT, Belgium–(BUSINESS WIRE)– MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics—today announced that its Type-2 Diabetes Program, developed in collaboration...

JT Included in the Dow Jones Sustainability Asia Pacific Index for the Ninth Consecutive Year

TOKYO–(BUSINESS WIRE)– Japan Tobacco Inc. (JT) (TSE: 2914) announces today that it has been included in the Dow Jones Sustainability Asia Pacific Index (“DJSI Asia...

IFF Recognized by EDGE for Commitment to Workplace Diversity

First company to receive Move-level certification twice from EDGE, the leading global assessment and business certification for gender and intersectional equity NEW YORK–(BUSINESS WIRE)– IFF...

Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA

– Novel, inhaled mRNA therapy intended for the ~5,000 people with CF who cannot benefit from CFTR modulators – – VX-522 clinical trial in people...